Events

Clean Aviation - Call for Proposals - Online Info Day
MAR
Tue
04

This was 8 months ago

Location

Online

Programmes
Climate, Energy, Mobility

Clean Aviation partnership has announced its third Call for Proposals, expected in February 2025.

This call will feature a total EU funding of up to €380 million corresponding to a minimum of €950(1) million of total research effort to support disruptive projects aimed at decarbonising aviation. 

On 4 March 2025, an Online Info Day will be held by Clean Aviation, providing guidance on preparing and consolidating proposals.

Call Milestones

  • 9 December: Pre-publication of the list of topics identified in the third Call for Proposals with a short abstract. 
  • 30 January: Pre-publication of the draft amended work programme 2024-2025(3) including the topic descriptions for the third Call for Proposals. 
  • 13 February 2025: PITCH-ATHLON (Brussels and online), hosted by Clean Aviation, where potential participants can pitch in person their ideas for Proposals and discuss them with relevant parties. More information on this event can be found here! 
  • End of February 2025: Launch of the Call for Proposals. 
  • 4 March 2025: Clean Aviation Online Info Day

For more information, please access the Clean Aviation partnership page.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.